Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces

Wagner, 2007, Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors, Stem Cells, 25, 2638, 10.1634/stemcells.2007-0280 Mareschi, 2006, Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis, Neurol Res, 28, 523, 10.1179/016164106X116791 Jacobs, 2013, Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells, Immunol Cell Biol, 91, 32, 10.1038/icb.2012.64 Wada, 2000, Immunomodulatory effects of stem cells, Periodontology, 2013, 198 Ren, 2008, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell, 2, 141, 10.1016/j.stem.2007.11.014 Zhukareva, 2010, Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli, Cytokine, 50, 317, 10.1016/j.cyto.2010.01.004 Caplan, 2006, Mesenchymal stem cells as trophic mediators, J Cell Biochem, 98, 1076, 10.1002/jcb.20886 Muraglia, 2000, Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model, J Cell Sci, 113, 1161, 10.1242/jcs.113.7.1161 Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 2849, 143, 10.1126/science.284.5411.143 Sohni, 2013, Mesenchymal stem cells migration homing and tracking, Stem Cells Int, 2013, 130763, 10.1155/2013/130763 Vertelov, 2013, High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA, Stem Cell Res Ther, 4, 5, 10.1186/scrt153 Li, 2011, Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms, Front Med, 5, 33, 10.1007/s11684-011-0114-1 Li, 2008, Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing, Cell Transplant, 17, 1045, 10.3727/096368908786991551 van Velthoven, 2013, Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke, Stroke, 44, 1426, 10.1161/STROKEAHA.111.000326 Honmou, 2011, Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke brain, 134, 1790 Doeppner, 2010, Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities, Stem Cells Cloning, 3, 157 Cashman, 2013, Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms, Stem Cell Rev, 9, 254, 10.1007/s12015-012-9375-6 Schuleri, 2007, Mesenchymal stem cells for cardiac regenerative therapy, Handb Exp Pharmacol, 180, 195, 10.1007/978-3-540-68976-8_9 Choi, 2011, Mesenchymal stem cells for cardiac cell therapy, Hum Gene Ther, 22, 3, 10.1089/hum.2010.211 Boyle, 2010, Mesenchymal stem cell therapy for cardiac repair, Methods Mol Biol, 660, 65, 10.1007/978-1-60761-705-1_5 Park, 2012, Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans, Neurosurgery, 70, 1238, 10.1227/NEU.0b013e31824387f9 Hu, 2010, Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells, Crit Care Med, 38, 2181, 10.1097/CCM.0b013e3181f17c0e Oliveri, 2014, Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury. Systematic review with meta-analyses of rat models, Neurobiol Dis, 62, 338, 10.1016/j.nbd.2013.10.014 Uccelli, 2013, Mesenchymal stem cells as treatment for MS – progress to date, Mult Scler, 19, 515, 10.1177/1352458512464686 Dalby, 2007, Nanotopographical control of human osteoprogenitor differentiation, Curr Stem Cell Res Ther, 2, 129, 10.2174/157488807780599220 Maclaine, 2012, Optimizing the osteogenicity of nanotopography using block co-polymer phase separation fabrication techniques, J Orthop Res, 30, 1190, 10.1002/jor.22076 Dalby, 2007, The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder, Nat Mater, 6, 997, 10.1038/nmat2013 Dalby, 2014, Harnessing nanotopography and integrin–matrix interactions to influence stem cell fate, Nat Mater, 13, 558, 10.1038/nmat3980 McNamara, 2014, Investigation of the limits of nanoscale filopodial interactions, J Tissue Eng, 5, 10.1177/2041731414536177 Affrossman, 2000, Surface structure of thin film blends of polystyrene and poly (n-butylmethacrylate), Colloid Polym Sci, 278, 993, 10.1007/s003960000358 Affrossman, 2000, The effect of molecular weight and the topography of thin films of blends of poly-(4-bromostyrene) and polystyrene, Colloid Polym Sci, 278, 888, 10.1007/s003960000359 Cheng, 2002, Fabrication of nanostructures with long-range order using block copolymer lithography, Appl Phys Lett, 81, 3657, 10.1063/1.1519356 Krishnamoorthy, 2006, Block copolymer micelles as switchable templates for nanofabrication, Langmuir, 22, 3450, 10.1021/la052299a Krishnamoorthy, 2006, Tuning the dimensions and periodicities of nanostructures starting from the same polystyrene-block-poly(2-vinylpyridine) diblock copolymer, Adv Funct Mater, 16, 1469, 10.1002/adfm.200500524 Tomé, 2009, Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa, Stem Cells, 27, 2196, 10.1002/stem.130 Murrell, 2005, Multipotent stem cells from adult olfactory mucosa, Dev Dyn, 233, 496, 10.1002/dvdy.20360 Delorme, 2010, The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties, Stem Cells Dev, 19, 853, 10.1089/scd.2009.0267 Schwob, 2002, Neural regeneration and the peripheral olfactory system, Anat Rec, 269, 33, 10.1002/ar.10047 Doucette, 1990, Glial influences on axonal growth in the primary olfactory system, Glia, 3, 433, 10.1002/glia.440030602 Farbman, 1990, Olfactory neurogenesis: genetic or environmental controls?, Trends Neurosci, 13, 362, 10.1016/0166-2236(90)90017-5 Lindsay, 2013, Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro, Glia, 61, 368, 10.1002/glia.22440 Li, 2009, MSCs guide neurite directional extension and promote oligodendrogenesis in NSCs, Biochem Biophys Res Commun, 384, 372, 10.1016/j.bbrc.2009.04.147 Rivera, 2009, Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures, Cell Physiol Biochem, 24, 317, 10.1159/000233256 Jadasz, 2013, Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation, PLoS One, 8, e71814, 10.1371/journal.pone.0071814 Lindsay, 2010, A complex tissue for a complex injury?, Glia, 58, 125, 10.1002/glia.20917 Dalby, 2006, Osteoprogenitor response to semi-ordered and random nanotopographies, Biomaterials, 27, 2980, 10.1016/j.biomaterials.2006.01.010 Chhabra, 2013, Stem cell therapy to cure type 1 diabetes: from hype to hope, Stem Cells Transl Med, 2, 328, 10.5966/sctm.2012-0116 Przybyt, 2013, Mesenchymal stem cells: promising for myocardial regeneration?, Curr Stem Cell Res Ther, 8, 270, 10.2174/1574888X11308040002 Liu, 2013, Stem cell applications in regenerative medicine for neurological disorders, Cell Transplant, 22, 631, 10.3727/096368912X655145 Thomsen, 2014, The past, present and future of stem cell clinical trials for ALS, Exp Neurol, 262, 127, 10.1016/j.expneurol.2014.02.021 Connick, 2012, Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study, Lancet Neurol, 11, 150, 10.1016/S1474-4422(11)70305-2 Lv, 2014, Concise review: the surface markers and identity of human mesenchymal stem cells, Stem Cells, 32, 1408, 10.1002/stem.1681 Chen, 2007, Clonal analysis of nestin(−) vimentin(+) multipotent fibroblasts isolated from human dermis, J Cell Sci, 120, 2875, 10.1242/jcs.03478 Foudah, 2014, Expression of neural markers by undifferentiated mesenchymal-like stem cells from different sources, J Immunol Res, 2014, 987678, 10.1155/2014/987678 Saura, 2013, Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker, Oncologist, 18, 787, 10.1634/theoncologist.2013-0075 Locher, 2013, Class III β-tubulin, a novel biomarker in the human melanocyte lineage, Differentiation, 85, 173, 10.1016/j.diff.2013.05.003 Wang, 2013, Highexpression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer, Clin Breast Cancer, 13, 103, 10.1016/j.clbc.2012.11.003 Kasantikul, 1989, Positivity to glial fibrillary acidic protein in bone, cartilage, and chordoma, J Surg Oncol, 41, 22, 10.1002/jso.2930410109 Mendez-Ferrer, 2010, Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature, 466, 829, 10.1038/nature09262 Lendahl, 1990, CNS stem cells express a new class of intermediate filament protein, Cell, 60, 585, 10.1016/0092-8674(90)90662-X Pinho, 2013, PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion, J Exp Med, 210, 1351, 10.1084/jem.20122252